Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis

Research output: Contribution to journalArticle

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) affecting more than two million people worldwide. As the exact etiology of MS remains elusive, the diagnosis of MS is made by referring to the McDonald diagnostic criteria, which utilizes MRI as a tool to identify "demyelinated" MS lesions. In particular, hyperintense lesions on T2-weighted images (T2WI) or so-called "T2-lesions" are considered to represent demyelinated MS lesions. T2WI, however, lacks myelin specificity, and moreover, remyelination could not be depicted by the use of such modality. For the accurate diagnosis and treatment decision-making, or for the future development of remyelination therapeutics, imaging tools to visualize myelin-specific signals are mandatory. In this chapter, the current use and the limitation of imaging modalities in MS diagnosis and treatment will be reviewed, with the introduction of new imaging method, namely q-space Myelin Map (qMM), to be used for visualization of demyelination and remyelination in MS.

Original languageEnglish
Pages (from-to)249-256
Number of pages8
JournalAdvances in experimental medicine and biology
Volume1190
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Myelin Sheath
Multiple Sclerosis
Visualization
Imaging techniques
Monitoring
Neurology
Magnetic resonance imaging
Demyelinating Diseases
Decision making
Decision Making
Central Nervous System

Keywords

  • Demyelination
  • MRI
  • Multiple sclerosis
  • q-space Myelin Map
  • Remyelination

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{c9be0c6303f64faf8b71d63c6d0b88b2,
title = "Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis",
abstract = "Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) affecting more than two million people worldwide. As the exact etiology of MS remains elusive, the diagnosis of MS is made by referring to the McDonald diagnostic criteria, which utilizes MRI as a tool to identify {"}demyelinated{"} MS lesions. In particular, hyperintense lesions on T2-weighted images (T2WI) or so-called {"}T2-lesions{"} are considered to represent demyelinated MS lesions. T2WI, however, lacks myelin specificity, and moreover, remyelination could not be depicted by the use of such modality. For the accurate diagnosis and treatment decision-making, or for the future development of remyelination therapeutics, imaging tools to visualize myelin-specific signals are mandatory. In this chapter, the current use and the limitation of imaging modalities in MS diagnosis and treatment will be reviewed, with the introduction of new imaging method, namely q-space Myelin Map (qMM), to be used for visualization of demyelination and remyelination in MS.",
keywords = "Demyelination, MRI, Multiple sclerosis, q-space Myelin Map, Remyelination",
author = "Jin Nakahara",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-981-32-9636-7_15",
language = "English",
volume = "1190",
pages = "249--256",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis

AU - Nakahara, Jin

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) affecting more than two million people worldwide. As the exact etiology of MS remains elusive, the diagnosis of MS is made by referring to the McDonald diagnostic criteria, which utilizes MRI as a tool to identify "demyelinated" MS lesions. In particular, hyperintense lesions on T2-weighted images (T2WI) or so-called "T2-lesions" are considered to represent demyelinated MS lesions. T2WI, however, lacks myelin specificity, and moreover, remyelination could not be depicted by the use of such modality. For the accurate diagnosis and treatment decision-making, or for the future development of remyelination therapeutics, imaging tools to visualize myelin-specific signals are mandatory. In this chapter, the current use and the limitation of imaging modalities in MS diagnosis and treatment will be reviewed, with the introduction of new imaging method, namely q-space Myelin Map (qMM), to be used for visualization of demyelination and remyelination in MS.

AB - Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) affecting more than two million people worldwide. As the exact etiology of MS remains elusive, the diagnosis of MS is made by referring to the McDonald diagnostic criteria, which utilizes MRI as a tool to identify "demyelinated" MS lesions. In particular, hyperintense lesions on T2-weighted images (T2WI) or so-called "T2-lesions" are considered to represent demyelinated MS lesions. T2WI, however, lacks myelin specificity, and moreover, remyelination could not be depicted by the use of such modality. For the accurate diagnosis and treatment decision-making, or for the future development of remyelination therapeutics, imaging tools to visualize myelin-specific signals are mandatory. In this chapter, the current use and the limitation of imaging modalities in MS diagnosis and treatment will be reviewed, with the introduction of new imaging method, namely q-space Myelin Map (qMM), to be used for visualization of demyelination and remyelination in MS.

KW - Demyelination

KW - MRI

KW - Multiple sclerosis

KW - q-space Myelin Map

KW - Remyelination

UR - http://www.scopus.com/inward/record.url?scp=85075507856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075507856&partnerID=8YFLogxK

U2 - 10.1007/978-981-32-9636-7_15

DO - 10.1007/978-981-32-9636-7_15

M3 - Article

C2 - 31760648

AN - SCOPUS:85075507856

VL - 1190

SP - 249

EP - 256

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -